[
    [
        {
            "time": "",
            "original_text": "智飞生物深度报告:产品及研发管线存在显著预期差,疫苗绝对龙头长期市值有望突破2000亿",
            "features": {
                "keywords": [
                    "智飞生物",
                    "产品",
                    "研发管线",
                    "预期差",
                    "疫苗",
                    "绝对龙头",
                    "长期市值",
                    "2000亿"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物深度报告:产品及研发管线存在显著预期差,疫苗绝对龙头长期市值有望突破2000亿",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]